Literature DB >> 21576601

Transplant tolerance: bench to bedside--26th annual Samuel Jason Mixter Lecture.

David H Sachs1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576601      PMCID: PMC3285481          DOI: 10.1001/archsurg.2011.101

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


× No keyword cloud information.
  22 in total

1.  Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death.

Authors:  T Wekerle; J Kurtz; M Sayegh; H Ito; A Wells; S Bensinger; J Shaffer; L Turka; M Sykes
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

2.  Predictors of organ allograft tolerance following hematopoietic cell transplantation.

Authors:  B M Horner; R A Cina; K J Wikiel; B Lima; A Ghazi; D P Lo; K Yamada; D H Sachs; C A Huang
Journal:  Am J Transplant       Date:  2006-12       Impact factor: 8.086

3.  Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses.

Authors:  Y Fudaba; T R Spitzer; J Shaffer; T Kawai; T Fehr; F Delmonico; F Preffer; N Tolkoff-Rubin; B R Dey; S L Saidman; A Kraus; T Bonnefoix; S McAfee; K Power; K Kattleman; R B Colvin; D H Sachs; A B Cosimi; M Sykes
Journal:  Am J Transplant       Date:  2006-06-22       Impact factor: 8.086

Review 4.  Mechanisms of tolerance induced via mixed chimerism.

Authors:  Megan Sykes
Journal:  Front Biosci       Date:  2007-05-01

5.  Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft.

Authors:  I Koyama; O Nadazdin; S Boskovic; T Ochiai; R N Smith; M Sykes; H Sogawa; T Murakami; T B Strom; R B Colvin; D H Sachs; G Benichou; A B Cosimi; T Kawai
Journal:  Am J Transplant       Date:  2007-02-07       Impact factor: 8.086

6.  Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model.

Authors:  C A Huang; Y Fuchimoto; R Scheier-Dolberg; M C Murphy; D M Neville; D H Sachs
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

7.  Mixed chimerism and tolerance without whole body irradiation in a large animal model.

Authors:  Y Fuchimoto; C A Huang; K Yamada; A Shimizu; H Kitamura; R B Colvin; V Ferrara; M C Murphy; M Sykes; M White-Scharf; D M Neville; D H Sachs
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

8.  HLA-mismatched renal transplantation without maintenance immunosuppression.

Authors:  Tatsuo Kawai; A Benedict Cosimi; Thomas R Spitzer; Nina Tolkoff-Rubin; Manikkam Suthanthiran; Susan L Saidman; Juanita Shaffer; Frederic I Preffer; Ruchuang Ding; Vijay Sharma; Jay A Fishman; Bimalangshu Dey; Dicken S C Ko; Martin Hertl; Nelson B Goes; Waichi Wong; Winfred W Williams; Robert B Colvin; Megan Sykes; David H Sachs
Journal:  N Engl J Med       Date:  2008-01-24       Impact factor: 91.245

Review 9.  Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview.

Authors:  Dela Golshayan; Manuel Pascual
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen.

Authors:  Y Sharabi; D H Sachs
Journal:  J Exp Med       Date:  1989-02-01       Impact factor: 14.307

View more
  3 in total

Review 1.  State of the art of clinical islet transplantation and novel protocols of immunosuppression.

Authors:  A M James Shapiro
Journal:  Curr Diab Rep       Date:  2011-10       Impact factor: 4.810

2.  Effects of FVIII immunity on hepatocyte and hematopoietic stem cell-directed gene therapy of murine hemophilia A.

Authors:  Allison M Lytle; Harrison C Brown; Na Yoon Paik; Kristopher A Knight; J Fraser Wright; H Trent Spencer; Christopher B Doering
Journal:  Mol Ther Methods Clin Dev       Date:  2016-02-10       Impact factor: 6.698

Review 3.  Progress towards xenogenic tolerance.

Authors:  Erin M Duggan; Adam Griesemer
Journal:  Curr Opin Organ Transplant       Date:  2020-10       Impact factor: 2.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.